Details for Patent: 11,707,464
✉ Email this page to a colleague
Which drugs does patent 11,707,464 protect, and when does it expire?
Patent 11,707,464 protects ORILISSA and is included in one NDA.
This patent has eight patent family members in five countries.
Drugs Protected by US Patent 11,707,464
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | ORILISSA | elagolix sodium | TABLET;ORAL | 210450-001 | Jul 23, 2018 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | MANAGEMENT OF MODERATE TO SEVERE PAIN ASSOCIATED WITH ENDOMETRIOSIS USING 150 MG ELAGOLIX FOR UP TO 24 MONTHS | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,707,464
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2906894 | ⤷ Subscribe | |||
| European Patent Office | 2968566 | ⤷ Subscribe | |||
| European Patent Office | 3384930 | ⤷ Subscribe | |||
| European Patent Office | 4223298 | ⤷ Subscribe | |||
| Japan | 2016513708 | ⤷ Subscribe | |||
| Japan | 6159870 | ⤷ Subscribe | |||
| New Zealand | 731834 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
